Psychiatry Research
Volume 109, Issue 3 , Pages 221-228 , 15 April 2002

Relationship of temperament and behaviour measures to the prolactin response to fenfluramine in depressed men

Received 23 May 2001 ,Revised 15 January 2002 ,Accepted 25 January 2002.

References 

  1. Åsberg M, Schalling D, Träskman-Bendz L. The psychobiology of suicide, impulsivity and related phenomena. In:  Meltzer H editors. Psychopharmacology: The Third Generation of Progress. New York: Raven Press; 1987;p. 655–688
  2. Åsberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Archives of General Psychiatry. 1976;33:1193–1197
  3. Barratt E. Impulsiveness defined within a systems model of personality. In:  Butcher JN,  Spielberger CD editor. Advances in Personality Assessment. Hillsdale, NJ: Lawrence Erlbaum Associates; 1985;
  4. Brody JF. Behavioral effects of serotonin depletion and of p-chlorophenylalanine (a serotonin depletor) in rats. Psychopharmacology. 1969;7:14–33
  5. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments. 1986;4:167–226
  6. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Archives of General Psychiatry. 1987;44:573–588
  7. Cloninger CR. The genetics and psychobiology of the seven-factor model of personality. In:  Silk KR editors. Biology of Personality Disorders. Washington, DC: American Psychiatric Press; 1998;p. 63–92
  8. Coccaro EF, Berman ME, Kavoussi RJ, Hauger RL. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biological Psychiatry. 1996;40:157–164
  9. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Archives of General Psychiatry. 1989;46:587–599
  10. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacology Bulletin. 1973;9:13–28
  11. Dolan M, Anderson IM, Deakin JFW. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. British Journal of Psychiatry. 2001;178:352–359
  12. Eysenck HJ, Eysenck SBJ. Manual of the Eysenck Personality Questionnaire. London: Hodder and Stoughton; 1975;
  13. Fishbein DH, Lozovsky D, Jaffe JH. Impulsivity, aggression and neuroendocrine responses to serotonergic stimulation in substance abusers. Biological Psychiatry. 1989;25:1049–1066
  14. Garvey MJ, Noyes R, Cook B, Blum N. Preliminary confirmation of the proposed link between reward-dependence traits and norepinephrine. Psychiatry Research. 1996;65:61–64
  15. Halperin JM, Newcorn JH, Schwartz ST, Sharma V, Siever LJ, Koda VH, et al. Age-related changes in the association between serotonergic function and aggression in boys with ADHD. Biological Psychiatry. 1997;41:682–689
  16. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology. 1967;6:278–296
  17. Hansenne M, Ansseau M. Catecholaminergic function and temperament in major depressive disorder: a negative report. Psychoneuroendocrinology. 1998;23:477–483
  18. Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF. Aggression, impulsivity and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology. 1998;19:287–299
  19. McBride PA, Tierney H, DeMeo M, Chen JS, Mann JJ. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biological Psychiatry. 1990;27:1143–1155
  20. Miczek KA, Altman JL, Appel JB, Boggan WO. Parachlorophenylalanine, serotonin and behavior. Journal of Pharmacology, Biochemistry and Behavior. 1975;3:961–968
  21. Muldoon MF, Manuck SB, Jansma CL, Moore AL, Perel J, Mann JJ. d,l-Fenfluramine challenge test: experience in nonpatient sample. Biological Psychiatry. 1996;39:761–768
  22. Nelson EC, Cloninger CR, Przybeck TR, Csernansky JG. Platelet serotonergic markers and Tridimensional Personality Questionnaire measures in a clinical sample. Biological Psychiatry. 1996;40:271–278
  23. Netter P, Hennig J, Rohrmann S. Psychobiological differences between the aggression and psychoticism dimension. Pharmacopsychiatry. 1999;32:5–12
  24. New AS, Trestman RL, Mitropoulou V, Benishay DS, Coccaro E, Silverman J, et al. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Research. 1997;69:17–26
  25. Newman ME, Shapira B, Lerer B. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. International Journal of Neuropsychopharmacology. 1998;1:49–69
  26. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. British Journal of Psychiatry. 1992;160:643–646
  27. O'Keane V, O'Hanlon M, Webb M, Dinan T. d-Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration. Clinical Endocrinology. 1991;34:289–292
  28. Pfohl B, Black D, Noyes R, Kelley M, Blum N. A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive–compulsive disorder. Biological Psychiatry. 1990;28:41–46
  29. Reist C, Mazzanti C, Vu R, Tran D, Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. American Journal of Medical Genetics: Neuropsychiatric Genetics. 2001;105:363–368
  30. Roy A, Ågren H, Pickar D, Linnoila M, Doran AR, Cutler NR, et al. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. American Journal of Psychiatry. 1986;143:1539–1545
  31. Roy A, Linnoila M. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatrica Scandinavica. 1988;78:529–535
  32. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behavior. Behavior and Brain Sciences. 1986;9:319–364
  33. Southwick SM, Paige S, Morgan 3rd CA, Bremner JD, Krystal JH, Charney DS. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Seminars in Clinical Neuropsychiatry. 1999;4:242–248
  34. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale and description. Archives of General Psychiatry. 1992;49:624–629
  35. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-11, 3/1/87). New York: Biometrics Research Department, New York State Psychiatric Institute; 1987;
  36. Stoff DM, Pasatiempo AP, Yeung JH, Bridger WH, Rabinovich H. Test–retest reliability of the prolactin and cortisol responses to dl-fenfluramine challenge in disruptive behavior disorders. Psychiatry Research. 1992;42:65–72
  37. Träskman L, Åsberg M, Bertilsson L, Sjöstrand L. Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry. 1981;38:631–636
  38. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M. Cerebrospinal fluid monoamine metabolite levels in male arsonists. Archives of General Psychiatry. 1987;44:241–247
  39. Wetzler S, Kahn RS, Asnis GM, Korn M, van Praag HM. Serotonin receptor sensitivity and aggression. Psychiatry Research. 1991;37:271–279
  40. Wiesbeck GA, Mauerer C, Thome J, Jakob F, Boening J. Neuroendocrine support for a relationship between ‘novelty seeking’ and dopaminergic function in alcohol-dependent men. Psychoneuroendocrinology. 1995;20:755–761

PII: S0165-1781(02)00018-5

Psychiatry Research
Volume 109, Issue 3 , Pages 221-228 , 15 April 2002

Article Tools